Abstract
Myelodysplastic syndromes (MDS) constitute a group of diverse disorders characterized by bone marrow (BM) dysplasia of one or more hemopoietic lineages and peripherally by varying degrees of anemia, leukopenia, and thrombocytopenia. Diagnosis is based mainly on examination of smears of aspirates which, however, may sometimes be inadequate because of failure to obtain sufficient material. For this reason a BM core biopsy is always recommended in order to better evaluate some morphological parameters such as overall cellularity, presence of reticulin fibrosis, and particularly degree of blastic infiltration. Furthermore, studies on BM sections have demonstrated some discrepancies in the criteria of the FAB Cooperative Group [1], so that a modified classification of MDS on the basis of histological findings has been proposed [2].
This work was supported by the Italian National Research Council (CNR, Progetto finalizzato Oncologia, Contract no. 87.01326.44). Institute of Medical Sciences, University of Milan, Italy
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Reference
Bennett JM, Catovsky D, Daniel MT, Flandrin G, Galton DAG, Gralnick HR, Sultan C (1982) Proposals for the classification of the myelodysplastic syndromes. Br J Haematol 51: 189–199
Frisch B, Schlag R, Bartl R. Kettner G, Burkhardt R (1983) Histologic characteristics of myelodysplasia. Verh Dtsch Ges Path 67: 132–135
Hanjan SN, Kearney JF, Cooper MDx (1982) A monoclonal antibody ( MMA) that identifies a differentiation antigen on human myelomonocytic cells. Clin Immunol Immunopathol 23: 172–188
Soligo D, Cattoretti G, Polli N, D’Amato L, Colombi M, Delia D. Schirò R, Berti E, Rilke F, Lambertenghi-Deliliers G (1986) Immunohistochemical reactivity of antiplatelet monoclonal antibodies in bone marrow and tissues. In: McMichael A (ed) Leukocyte typing III., Oxford University Press, Oxford, pp 766–768
Cordell JL, Falini B, Erber WN, Ghosh AK, Abdulaziz Z, MacDonald S, Pulford KAF, Stein H, Mason DY (1984) Immunoenzymatic labeling of monoclonal antibodies using immune complexes of alkaline phosphatase and monoclonal anti-alkaline phosphatase ( APAAP) complexes. J Histochem Cytochem 32: 219–229
Delacrétaz F, Schmidt PM, Pignet D, Bachmann F, Costa J (1987) Histopathology of myelodysplastic syndromes. Am J Clin Pathol 87: 180–186
Tricot G, De Wolf-Peeters C, Hendrickx B, Verwilghen RL (1984) Bone marrow histology in myelodysplastic syndromes. I. Histological findings in myelodysplastic syndromes and comparison with bone marrow smears. Br J Haematol 57: 423–430
Frisch B, Lewis SM, Burkhardt T, Bartl R (1985) Biopsy pathology of bone and bone marrow. Chapman and Hall, London, pp 146–179
Gladson CL, Naeim F (1986) Hypocellular bone marrow with increased blasts. Am J Hematol 21: 15–22
Mufti GJ, Galton DAG (1986) Myelodysplastic syndromes: natural history and features of prognostic importance. Clin. Haematol 15: 953–971
Shibata A, Takahashi M, Koike T, Narita M, Moriyama Y (1988) Myelodysplastic syndrome with myelofibrosis: a report of seven cases. Blut 56: 15
Tricot G, De Wolf-Peeters C, Vlietinck R, Verwilghen RL (1984) Bone marrow histology in myelodysplastic syndromes. II. Prognostic value of abnormal localization of immature precursors in MDS. Br J Haematol 58: 217–225
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1992 Springer-Verlag Berlin Heidelberg
About this paper
Cite this paper
Lambertenghi-Deliliers, G., Soligo, D., Annaloro, C., Pozzoli, E., Riva, A. (1992). Bone Marrow Biopsy in RAEB and RAEB-t Myelodysplastic Syndromes. In: Schmalzl, F., Mufti, G.J. (eds) Myelodysplastic Syndromes. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-75952-9_11
Download citation
DOI: https://doi.org/10.1007/978-3-642-75952-9_11
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-52966-8
Online ISBN: 978-3-642-75952-9
eBook Packages: Springer Book Archive